Skip to main content
Zylox-Tonbridge Medical Technology Co., Ltd. logo

Zylox-Tonbridge Medical Technology Co., Ltd. — Investor Relations & Filings

Ticker · 2190 LEI · 254900QSIU3I0P3OEJ92 HKEX Manufacturing
Open in API
Filings indexed 513 across all filing types
Latest filing 2026-03-30 Transaction in Own Shar…
Country CN China
Listing HKEX 2190

About Zylox-Tonbridge Medical Technology Co., Ltd.

http://www.zyloxtb.com

Zylox-Tonbridge Medical Technology Co., Ltd. is an integrated solution provider specializing in the research, development, and commercialization of neurovascular and peripheral vascular interventional medical devices. Recognized as a leading player in the market for high-value-added vascular medical devices, the company offers a comprehensive portfolio of revascularization products, including over 40 quality devices. Dedicated to advancing healthcare through cutting-edge technologies, Zylox-Tonbridge focuses on providing solutions for complex vascular conditions and is actively expanding its presence in the global medical technology market.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return under HKEx Main Board and GEM listing rules (FF305) detailing changes in issued shares, treasury shares, and share repurchases (on-market buybacks) by the issuer. It includes repurchase dates, quantities, prices, opening/closing balances, and confirmations required by listing rule 13.25A/10.06B, which is a transaction in the issuer’s own shares. This matches the definition of Transaction in Own Shares (POS).
2026-03-30 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) under Hong Kong Stock Exchange rules that reports changes in issued shares and treasury shares, specifically detailing share repurchases, treasury share sales, and confirmations of compliance. It is a regulatory disclosure of the company buying back its own shares. This matches the definition for Transaction in Own Shares (Code: POS).
2026-03-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) filed under Hong Kong Stock Exchange Main Board Rules/GEM Rules detailing changes in issued shares and treasury shares and reporting the on-market repurchase of its own shares (100,000 shares repurchased, price details, mandate information, confirmations). This is not an earnings release or annual report but a formal disclosure of a share buyback transaction. It therefore falls under “Transaction in Own Shares” (share repurchase) category (POS).
2026-03-26 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a regulatory disclosure (Next Day Disclosure Return) under the Hong Kong Stock Exchange listing rules, detailing changes in issued shares and on-market repurchases/treasury share transactions. It is not an annual or interim report, earnings release, or AGM material, but a transaction notice of the company’s own shares. This matches the ‘Transaction in Own Shares’ category (POS).
2026-03-25 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) detailing changes in issued shares and treasury shares, specifically share repurchases on the exchange. It is a regulatory filing reporting the company’s own share buybacks rather than announcing an earnings, dividend, or AGM material. Therefore it falls under Transaction in Own Shares (POS).
2026-03-24 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Exchange “Next Day Disclosure Return” (Form FF305) detailing changes in issued shares, treasury shares, and on‐market share repurchases by Zylox-Tonbridge Medical Technology Co., Ltd. It provides specific figures for shares bought back and held as treasury shares, repurchase prices, aggregate amounts, and compliance confirmations under HKEX Listing Rules. This is a direct report of the company’s own share transactions. According to the classification definitions, it matches “Transaction in Own Shares” (Code: POS).
2026-03-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.